Recombinant Anaxyrus americanus Transcription factor IIIA (gtf3a)

Shipped with Ice Packs
In Stock

Description

Definition and Origin

Recombinant Anaxyrus americanus GTF3A is a laboratory-engineered version of the transcription factor IIIA derived from the American toad (Anaxyrus americanus). It facilitates 5S rRNA synthesis by binding to the internal control region (ICR) of 5S rRNA genes and is critical for RNA polymerase III (Pol III) complex assembly . The recombinant form is expressed in heterologous systems (e.g., yeast) and tagged for purification, retaining functional properties akin to native TFIIIA .

Production and Purification

Recombinant GTF3A is synthesized using advanced expression systems:

  • Host Systems: Yeast (Saccharomyces cerevisiae) is the primary host for Anaxyrus GTF3A production .

  • Purity: >90% purity confirmed via SDS-PAGE and Western blot .

  • Yield: Optimized protocols ensure high yields, though specifics depend on expression scale .

DNA/RNA Binding

  • 5S rDNA Interaction: Binds the ICR (nucleotides +43 to +96) to initiate Pol III transcription .

  • Species-Specific Binding: Anaxyrus GTF3A protects the full ICR (+96 to +43) in DNase I assays, unlike Rana pipiens TFIIIA, which shows weaker protection downstream of +78 .

Role in Ribosome Biogenesis

GTF3A stabilizes 5S rRNA by forming a 7S ribonucleoprotein (RNP) complex, preventing degradation and enabling cytoplasmic transport . Dysregulation is implicated in diseases like colorectal cancer and herpes simplex encephalitis (HSE) .

Research Applications

ApplicationUtility
ELISADetects GTF3A expression levels in cellular studies .
Functional StudiesInvestigates Pol III activity, rRNA processing, and disease mechanisms .
Structural BiologyResolves DNA/RNA interaction dynamics via ChIP-seq and mutagenesis .

Cross-Species Variability

  • Sequence Divergence: Anaxyrus GTF3A shares <60% homology with frog orthologs, affecting DNA-binding specificity .

  • Functional Conservation: Despite sequence differences, all TFIIIA orthologs regulate 5S rRNA transcription and RNP assembly .

Future Directions

Current research focuses on:

  • Therapeutic Targeting: Blocking GTF3A to inhibit cancer progression .

  • Disease Modeling: Linking GTF3A mutations to immunodeficiency and HSE .

Product Specs

Form
Lyophilized powder. We will ship the available format, but you can specify your preferred format when ordering.
Lead Time
Delivery time varies by purchase method and location. Contact your local distributor for details. Proteins are shipped with blue ice packs by default. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freezing and thawing. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
gtf3a; Transcription factor IIIA; TFIIIA
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-339
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Anaxyrus americanus (American toad) (Bufo americanus)
Target Names
gtf3a
Target Protein Sequence
MGEKLPVVYK RFICSFPDCN ATYNKNRKLQ AHLCKHTGER PFPCTYEGCE KGFVTLHHLN RHVLSHTGEK PCKCETENCN LAFTTASNMR LHFKRAHSSP AQVYVCYFAD CGQQFRKHNQ LKIHQYIHTN QQPFKCSHEG CDKCYASPSR LKRHEKTHAG YPCRKDSTCP FVGKTWSDYM KHAAELHSEV TCSICNRTFK RKSFLKEHKK IHREERIVYR CPRENCDRTY TTKFNLKSHI LTFHENLRPF VCEHEGCGKT FAMKQSLDRH FNTHDPEKKK MVKPPRPVRS LASRLSGYKP KKSKKKKKPS QTPAMESQEQ QPDASKADPL PVLENLTLK
Uniprot No.

Target Background

Function
Involved in ribosomal large subunit biogenesis. Interacts with the 5S RNA gene's internal control region (ICR), enabling proper transcription by RNA polymerase III. Also binds transcribed 5S RNA.
Subcellular Location
Nucleus.

Q&A

What is the basic structure of A. americanus TFIIIA and how does it compare to other amphibian species?

  • Potential guanine nucleotide-binding sites at arginines in zinc fingers II, V, and IX

  • Acidic residues between metal-coordinating cysteines

  • A basic region in the C-terminal tail involved in transcription promotion

  • Sequence similarity in an amino acid stretch bridging the ninth ZnF and C-terminal tail

The 3'-untranslated regions of TFIIIA cDNAs reveal a non-conventional polyadenylation signal (ATTAAA rather than AATAAA) .

How do the DNA-binding properties of A. americanus TFIIIA differ from other amphibian TFIIIA proteins?

DNase I protection analyses demonstrate significant differences in how various amphibian TFIIIA proteins interact with the internal control region (ICR) of the 5S RNA gene:

  • B. americanus TFIIIA interaction is similar to X. laevis TFIIIA, protecting the entire 5S gene ICR (nucleotides +96 to +43) from DNase I digestion

  • R. pipiens TFIIIA strongly protects the ICR from nucleotides +96 to +78 and less strongly from +78 to +43

These binding differences may be explained by species-specific variations in 5S RNA structures. For instance, R. pipiens and R. catesbeiana oocyte 5S RNAs contain a G or U at nucleotide position 50, while B. americanus, X. laevis, and other eukaryotic 5S RNAs have an A in the analogous position .

What are the optimal methods for expression and purification of recombinant A. americanus TFIIIA?

Based on published protocols for similar transcription factors, we recommend the following methodological approach:

  • Gene Amplification: Design primers based on the published cDNA sequence, with attention to the unique polyadenylation signal (ATTAAA) .

  • Expression System Selection: E. coli BL21(DE3) cells are recommended for initial attempts, with the following considerations:

    • Include zinc supplementation (100-200 μM ZnCl₂) in the culture medium

    • Use a low induction temperature (16-18°C) to enhance proper folding

    • Consider co-expression with chaperones if solubility issues arise

  • Purification Strategy:

    • Two-step purification using affinity chromatography followed by size exclusion

    • Buffer conditions should maintain Zn²⁺ coordination (include 5-10 μM ZnCl₂)

    • Avoid chelating agents like EDTA throughout the purification process

How can researchers assess the functional integrity of recombinant TFIIIA?

Multiple complementary approaches should be employed:

  • DNA Binding Assays:

    • DNase I protection analysis to confirm binding to the ICR region of 5S RNA genes

    • Electrophoretic mobility shift assays (EMSA) with labeled 5S gene fragments

    • Surface plasmon resonance to determine binding kinetics

  • Structural Verification:

    • Circular dichroism spectroscopy to verify secondary structure

    • Limited proteolysis to assess proper folding

    • Zinc content analysis using atomic absorption spectroscopy

  • Functional Testing:

    • In vitro transcription assays using 5S RNA templates

    • Cell-based reporter assays if studying transcriptional activation

How do mutations in zinc finger domains affect TFIIIA function and what methods can detect these effects?

Mutations in zinc finger domains can substantially impact TFIIIA function. For example, mutations such as C195W and C219R in CCHH motifs result in decreased zinc affinity by four- to five-fold compared to wild-type .

Methodological approaches to study mutational effects:

  • Zinc Binding Analysis:

    • Isothermal titration calorimetry to quantify changes in zinc affinity

    • Inductively coupled plasma mass spectrometry (ICP-MS) to determine zinc-to-protein ratios

  • DNA Binding Assessment:

    • Quantitative DNase I footprinting with titration of protein concentrations

    • Fluorescence anisotropy with labeled DNA fragments

    • EMSA with competition assays to determine relative affinities

  • Structural Analysis:

    • X-ray crystallography or NMR to determine structural perturbations

    • Hydrogen/deuterium exchange mass spectrometry to assess conformational changes

  • Cellular Localization:

    • Confocal microscopy with GFP-fused wild-type or mutant proteins

    • Fractionation experiments with Western blot analysis

What is the dual role of TFIIIA in transcriptional regulation and immune function?

Recent research has revealed TFIIIA as a "moonlighting protein" with roles beyond 5S rRNA transcription. It also regulates innate immunity . This dual functionality presents intriguing research opportunities:

  • Transcriptional Regulation:

    • Primarily mediates 5S rRNA transcription through binding to the internal control region

    • Forms part of the transcription initiation complex with RNA polymerase III

  • Immune Regulation:

    • Regulates cellular RIG-I agonists

    • GTF3A genetic defects lead to impaired cell-intrinsic anti-HSV-1 responses

Experimental approaches to study dual functionality:

  • Chromatin Immunoprecipitation (ChIP):

    • Identify genome-wide binding sites beyond 5S rRNA genes

    • ChIP-seq to map binding patterns under different immune stimulation conditions

  • RNA Immunoprecipitation:

    • Identify RNA species bound by TFIIIA in different cellular contexts

    • Assess changes in RNA binding during immune challenges

  • Domain Mapping:

    • Create domain-specific mutations to separate transcriptional and immune functions

    • Domain swap experiments between species with different immune sensitivities

What metabolic pathways are potentially affected by alterations in TFIIIA function?

Based on metabolomic studies of A. americanus under environmental stress, the following pathways might be influenced by TFIIIA dysregulation:

PathwayTotalExpectedHitsRaw pImpactHolmes adjusted
Pentose phosphate pathway320.3530.000.090.36
Aminoacyl-tRNA biosynthesis750.8140.010.060.61
Galactose metabolism410.4430.010.000.71
Glycine, serine and threonine metabolism480.5230.010.421.00
Purine metabolism920.9940.020.021.00

Table 1: Metabolic pathways identified in A. americanus exposure studies that may intersect with TFIIIA function

Methodological approaches to investigate pathway interactions:

  • Integrated Omics:

    • Combine transcriptomics, proteomics, and metabolomics data

    • Use pathway enrichment analysis with KEGG or Reactome databases

    • Apply network analysis to identify regulatory hubs

  • Metabolic Flux Analysis:

    • Use isotope-labeled metabolites to trace pathway activities

    • Measure changes in metabolite pools upon TFIIIA perturbation

    • Correlate with 5S rRNA levels and ribosome biogenesis

How can researchers reconcile contradictory findings about TFIIIA function across different amphibian species?

Contradictory findings are common in comparative studies of transcription factors. To address these challenges:

  • Standardized Experimental Conditions:

    • Use consistent protein expression and purification protocols

    • Employ identical DNA binding assay conditions

    • Control for developmental stages and tissue types

  • Phylogenetic Approaches:

    • Conduct comprehensive sequence alignments across multiple species

    • Perform ancestral sequence reconstruction

    • Map functional differences onto evolutionary trees

  • Structural Biology Integration:

    • Develop homology models for species without crystal structures

    • Use molecular dynamics simulations to predict binding differences

    • Validate with experimental mutagenesis

  • Heterologous Expression Systems:

    • Express TFIIIA from multiple species in the same cellular background

    • Perform cross-species complementation assays

    • Use chimeric proteins to identify species-specific functional domains

What are the emerging techniques for studying TFIIIA-mediated transcriptional regulation in non-model amphibians?

Studying transcription factors in non-model organisms presents unique challenges. Here are cutting-edge approaches:

  • Genome Editing in Non-Model Systems:

    • CRISPR/Cas9 protocols optimized for A. americanus embryos

    • Homology-directed repair for precise mutations

    • Base editing for specific nucleotide changes

  • Single-Cell Approaches:

    • scRNA-seq to identify cell-specific TFIIIA expression patterns

    • scATAC-seq to map chromatin accessibility at TFIIIA binding sites

    • Spatial transcriptomics to visualize TFIIIA activity in intact tissues

  • Protein-DNA Interaction Mapping:

    • CUT&RUN or CUT&Tag as alternatives to ChIP-seq requiring less material

    • HiChIP to identify long-range chromatin interactions

    • SELEX-seq to determine DNA binding preferences

  • Functional Genomics Integration:

    • CRISPR interference/activation to modulate TFIIIA levels

    • Massively parallel reporter assays to test variant effects

    • Integrative analysis with epigenomic data

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.